Company Filing History:
Years Active: 2022-2025
Title: Trevor C Johnson: Innovator in MCL1 Inhibitors
Introduction
Trevor C Johnson is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of cancer treatment through his innovative work on MCL1 inhibitors. With a total of 5 patents to his name, Johnson is recognized for his expertise and dedication to advancing medical science.
Latest Patents
Johnson's latest patents focus on processes and intermediates for preparing MCL1 inhibitors. The first patent provides methods for preparing MCL1 inhibitors or a salt thereof, along with related key intermediates. The second patent relates to methods and intermediates for the synthesis of certain compounds that inhibit MCL1, specifically for use in the treatment of cancers. These patents highlight his commitment to developing effective therapies for challenging medical conditions.
Career Highlights
Trevor C Johnson is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His work at Gilead has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to cancer research and treatment.
Collaborations
Some of Johnson's notable coworkers include Darryl D Dixon and Michael A Ischay. Their collaborative efforts have played a crucial role in advancing the research and development of MCL1 inhibitors.
Conclusion
Trevor C Johnson's innovative work in the field of MCL1 inhibitors demonstrates his commitment to improving cancer treatment options. His patents and collaborations reflect his significant impact on medical research and the pharmaceutical industry.